Needle-free Injection System for Polio Vaccine Industry - Medical / Health Care - Pharmaceuticals

Doing Our Part in the Next Step Towards Polio Eradication

The WHO recommends 2 doses of IPV to minimize vaccine-derived poliovirus (VDPV). With Tropis, you can save costs on routine immunization and campaigns while increasing immunization coverage.

Key Benefits of Polio Vaccine Delivered Intradermally, Needle-free

Comparable Protection
Two intradermal doses of IPV (fIPV) provide the same or improved protection as two IM IPV doses. WHO endorses fIPV as a means of extending stocks and saving costs.

Reduces Costs
Countries transitioning from Gavi support can save tens of millions of dollars by switching to ID IPV delivered needle-free. We can show you how!

Easy to Roll Out
Needle-free injection systems are easy to learn. After about 20 minutes, most users are highly proficient. Experienced users would prefer to use needle-free